A genetic alteration appears to increase heart failure risk among people of African descent, according to the Washington Post.
A group led by Mount Sinai researchers said this methyltransferase, which is involved in sporulation, could be targeted to fight infections.
The new system, called BODE 2, will launch at the end of this year and will replace the existing BODE for the analysis of "big omics" data for research.
In Nature this week: immunomagnetic method for sorting cells, cumulative effects of rare and common risk variants in schizophrenia, and more.
Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.
The firm is part of a research consortium that is led by Mount Sinai and includes Fluidigm to develop a device to detect epigenetic signatures of WMD exposure.
The firm did not disclose the size of the funding, which is helping it build on its Centrellis Health Intelligence Platform and move to whole-exome sequencing.
Data from MMRF's Immune Atlas will be included in its recently launched CureCloud, a registry of clinical, genomic, and EHR data from multiple myeloma patients.
The former head of the Icahn Institute for Genomics and Multiscale Biology discussed how data quality can improve biomedical research and inform precision medicine.
The grant is part of a CZI effort to fund research projects supporting the Human Cell Atlas, which is building a reference atlas of all human cell types.
Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.
In his look back at the past decade, BuzzFeed News' Peter Aldhous writes that direct-to-consumer genetic testing has led to "Facebook for genes."
In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.